Captor Therapeutics S.A. (CTX) — Financial Flexibility Index
Captor Therapeutics S.A. (CTX) has a Financial Flexibility Index of -1.02x as of September 2025. Free cash flow of zł-11.51 Million (operating CF zł-11.51 Million minus capex zł0.00) represents -1% of total liabilities (zł11.27 Million). Check CTX capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Captor Therapeutics S.A. Financial Flexibility Index (2017–2024)
Historical Financial Flexibility Index trend for Captor Therapeutics S.A. across 8 annual periods. For the full cash flow conversion analysis, see how efficiently does Captor Therapeutics S.A. generate cash.
Annual Financial Flexibility Index for Captor Therapeutics S.A. (2017–2024)
Year-by-year free cash flow to debt coverage for Captor Therapeutics S.A.. Explore how well can Captor Therapeutics S.A. service its debt to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (PLN) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -1.37x | zł-31.45 Million | zł-31.88 Million | zł23.02 Million | ▲ +22.0% |
| 2023 | -1.75x | zł-49.20 Million | zł-52.20 Million | zł28.07 Million | ▼ -32.5% |
| 2022 | -1.32x | zł-22.06 Million | zł-22.95 Million | zł16.68 Million | ▼ -9.5% |
| 2021 | -1.21x | zł-23.36 Million | zł-28.47 Million | zł19.34 Million | ▼ -8346.5% |
| 2020 | -0.01x | zł-383.00K | zł-595.00K | zł26.78 Million | ▼ -106.5% |
| 2019 | 0.22x | zł4.62 Million | zł4.39 Million | zł21.02 Million | ▲ +258.5% |
| 2018 | -0.14x | zł-2.03 Million | zł-2.13 Million | zł14.63 Million | ▼ -133.0% |
| 2017 | 0.42x | zł2.10 Million | zł2.10 Million | zł4.98 Million | — |